Apeiron Investment Group Ltd. 13D and 13G filings for Neuphoria Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-28 4:30 pm Purchase |
2025-01-24 | 13D | Neuphoria Therapeutics Inc. NEUP |
Apeiron Investment Group Ltd. | 72,618 4.500% |
72,618 (New Position) |
Filing |